» Articles » PMID: 10477913

Effects of Radiation on Incidence of Primary Liver Cancer Among Atomic Bomb Survivors

Overview
Journal Radiat Res
Specialties Genetics
Radiology
Date 1999 Sep 9
PMID 10477913
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

We describe the radiation risk for primary liver cancers between 1958 and 1987 in a cohort of atomic bomb survivors in Hiroshima and Nagasaki, Japan. The analysis is based on a comprehensive pathology review of known or suspected liver neoplasms that generated 518 incident, first primary cases, mostly hepatocellular carcinoma. Excess relative risk from atomic bomb radiation was linear: 0.81 per sievert weighted liver dose (95% CI [0.32, 1.43]; P < 0.001). Males and females had similar relative risk so that, given a threefold higher background incidence in males, the radiation-related excess incidence was substantially higher in males. Excess risk peaked for those with age at exposure in the early 20s; there was essentially no excess risk in those exposed before age 10 or after age 45. Whether this was due to a difference in sensitivity or possible confounding by other factors could not be addressed retrospectively in the full cohort. A paucity of cholangiocarcinoma and hemangiosarcoma cases suggested that they are not significantly associated with whole-body radiation exposure, as they are with the internal alpha-particle-emitting radiological contrast medium Thorotrast. Because most of the radiation-related excess cases occurred among males, it is important to ascertain what factors put men at greater risk of radiation-related liver cancer.

Citing Articles

Radiation and Risk of Liver, Biliary Tract, and Pancreatic Cancers among Atomic Bomb Survivors in Hiroshima and Nagasaki: 1958-2009.

Sadakane A, French B, Brenner A, Preston D, Sugiyama H, Grant E Radiat Res. 2019; 192(3):299-310.

PMID: 31291162 PMC: 10273724. DOI: 10.1667/RR15341.1.


First mortality analysis in the French cohort of uranium millers (F-Millers), period 1968-2013.

Bouet S, Samson E, Jovanovic I, Laurier D, Laurent O Int Arch Occup Environ Health. 2017; 91(1):23-33.

PMID: 28861613 DOI: 10.1007/s00420-017-1254-7.


Cholangiocarcinoma following external beam radiotherapy: A report of two cases.

Kulkarni A, Gundara J, Gill A, Hugh T, Samra J Oncol Lett. 2017; 14(1):423-426.

PMID: 28693186 PMC: 5494849. DOI: 10.3892/ol.2017.6113.


Assessing liver proteins and enzymes of medical workers exposed to ionizing radiation (IR).

Shahid S, Masood K Clin Exp Med. 2017; 18(1):89-99.

PMID: 28493150 DOI: 10.1007/s10238-017-0462-5.


A suppressive role of ionizing radiation-responsive miR-29c in the development of liver carcinoma via targeting WIP1.

Wang B, Li D, Sidler C, Rodriguez-Juarez R, Singh N, Heyns M Oncotarget. 2015; 6(12):9937-50.

PMID: 25888625 PMC: 4496408. DOI: 10.18632/oncotarget.3157.